Healthcare provider profile · identity verified

Nabil A Elhadidy, MD

Internal Medicine · BRONX, NY · NPI 1548481898

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Metformin Hcl	Metformin Hcl	1150	172
Atorvastatin Calcium	Atorvastatin Calcium	1026	163
Amlodipine Besylate	Amlodipine Besylate	1019	159
Tamsulosin Hcl	Tamsulosin Hcl	800	134
Pantoprazole Sodium	Pantoprazole Sodium	796	139
Metoprolol Succinate	Metoprolol Succinate	699	104
Losartan Potassium	Losartan Potassium	610	78
Misoprostol	Misoprostol	567	89
Famotidine	Famotidine	455	86
Finasteride	Finasteride	445	64
Levothyroxine Sodium	Levothyroxine Sodium	444	66
Simvastatin	Simvastatin	378	44
Gabapentin	Gabapentin	375	74
Rosuvastatin Calcium	Rosuvastatin Calcium	363	51
Lisinopril	Lisinopril	327	66
Hydrochlorothiazide	Hydrochlorothiazide	317	46
Alendronate Sodium	Alendronate Sodium	288	46
Eliquis	Apixaban	274	55
Januvia	Sitagliptin Phosphate	254	38
Furosemide	Furosemide	253	56
Clopidogrel	Clopidogrel Bisulfate	232	39
Jardiance	Empagliflozin	227	38
Fenofibrate	Fenofibrate Nanocrystallized	214	27
Omeprazole	Omeprazole	190	29
Nifedipine Er	Nifedipine	174	29
Levetiracetam	Levetiracetam	160	24
Entresto	Sacubitril/Valsartan	154	26
Gemfibrozil	Gemfibrozil	154	23
Albuterol Sulfate Hfa	Albuterol Sulfate	152	45
Trulicity	Dulaglutide	149	30
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	127	31
Hydralazine Hcl	Hydralazine Hcl	113	20
Potassium Chloride	Potassium Chloride	111	30
Ranolazine Er	Ranolazine	111	17
Donepezil Hcl	Donepezil Hcl	102	23
Carvedilol	Carvedilol	101	16
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	98	21
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	88	21
Enalapril Maleate	Enalapril Maleate	88	12
Oxybutynin Chloride	Oxybutynin Chloride	86	11
Diclofenac Sodium	Diclofenac Sodium	84	29
Allopurinol	Allopurinol	81	11
Tizanidine Hcl	Tizanidine Hcl	79	19
Alcohol Prep Pads	Alcohol Antiseptic Pads	78	26
Glipizide	Glipizide	77	14
Midodrine Hcl	Midodrine Hcl	74	14
Montelukast Sodium	Montelukast Sodium	74	11
Carbidopa-Levodopa	Carbidopa/Levodopa	73	15
Fluticasone Propionate	Fluticasone Propionate	73	29
Diclofenac Potassium	Diclofenac Potassium	72	23
Sertraline Hcl	Sertraline Hcl	67	19
Metoprolol Tartrate	Metoprolol Tartrate	66	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	60	45
Novolog Flexpen	Insulin Aspart	57	24
Olanzapine	Olanzapine	57	15
Risperidone	Risperidone	54	19
Citalopram Hbr	Citalopram Hydrobromide	53	11
Ezetimibe	Ezetimibe	53	suppressed
Xarelto	Rivaroxaban	53	suppressed
Warfarin Sodium	Warfarin Sodium	51	suppressed
Valsartan	Valsartan	49	suppressed
Amiodarone Hcl	Amiodarone Hcl	46	suppressed
Incruse Ellipta	Umeclidinium Bromide	46	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	45	19
Divalproex Sodium	Divalproex Sodium	45	16
Latanoprost	Latanoprost	44	16
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	42	11
Insulin Aspart Flexpen	Insulin Aspart	39	18
Spironolactone	Spironolactone	39	suppressed
Methimazole	Methimazole	38	suppressed
Trazodone Hcl	Trazodone Hcl	38	14
Memantine Hcl	Memantine Hcl	37	suppressed
Divalproex Sodium Er	Divalproex Sodium	36	suppressed
Mirtazapine	Mirtazapine	36	suppressed
Vascepa	Icosapent Ethyl	36	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	34	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	33	suppressed
Farxiga	Dapagliflozin Propanediol	33	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	33	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	32	suppressed
Topiramate	Topiramate	32	suppressed
Bicalutamide	Bicalutamide	30	suppressed
Clotrimazole	Clotrimazole	30	11
Meclizine Hcl	Meclizine Hcl	30	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	30	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	30	suppressed
Baclofen	Baclofen	29	suppressed
Celecoxib	Celecoxib	29	suppressed
Duloxetine Hcl	Duloxetine Hcl	29	suppressed
Easy Touch Pen Needle	Pen Needle, Diabetic	29	suppressed
Clonazepam	Clonazepam	28	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	28	11
Myrbetriq	Mirabegron	27	suppressed
Ventolin Hfa	Albuterol Sulfate	27	suppressed
Clonidine	Clonidine	26	suppressed
Labetalol Hcl	Labetalol Hcl	25	suppressed
Levemir Flexpen	Insulin Detemir	25	suppressed
Oxycodone Hcl	Oxycodone Hcl	25	12
Sucralfate	Sucralfate	25	suppressed
Benztropine Mesylate	Benztropine Mesylate	24	suppressed
Clonidine Hcl	Clonidine Hcl	24	suppressed
Mupirocin	Mupirocin	24	15
Breo Ellipta	Fluticasone/Vilanterol	23	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	23	suppressed
Propranolol Hcl	Propranolol Hcl	23	suppressed
Atenolol	Atenolol	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Ozempic	Semaglutide	22	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	21	suppressed
Alcohol Swab	Alcohol Antiseptic Pads	21	suppressed
Dutasteride	Dutasteride	21	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	21	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	21	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	20	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	19	suppressed
Methocarbamol	Methocarbamol	19	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Calcium Acetate	Calcium Acetate	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Novofine Autocover	Pen Needle, Diabetic, Safety	18	suppressed
Torsemide	Torsemide	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	suppressed
Dropsafe Pen Needle	Pen Needle, Diabetic, Safety	17	suppressed
Metronidazole	Metronidazole	17	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	17	suppressed
Acetazolamide	Acetazolamide	16	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	16	suppressed
Lidocaine	Lidocaine	16	suppressed
Tobramycin-Dexamethasone	Tobramycin/Dexamethasone	16	11
Chlorhexidine Gluconate	Chlorhexidine Gluconate	14	suppressed
Cilostazol	Cilostazol	14	suppressed
Folic Acid	Folic Acid	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Carbamazepine Er	Carbamazepine	13	suppressed
Colchicine	Colchicine	13	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	13	suppressed
Metformin Hcl Er	Metformin Hcl	13	suppressed
Pravastatin Sodium	Pravastatin Sodium	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Acarbose	Acarbose	12	suppressed
Ammonium Lactate	Ammonium Lactate	12	suppressed
Anastrozole	Anastrozole	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Invega Sustenna	Paliperidone Palmitate	12	suppressed
Mesalamine	Mesalamine	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Azithromycin	Azithromycin	11	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	11	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	11	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Desmopressin Acetate	Desmopressin Acetate	11	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	11	suppressed
Lactulose	Lactulose	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error